Literature DB >> 17934822

A new rat model links two contemporary theories in irritable bowel syndrome.

Mark Pimentel1, Soumya Chatterjee, Christopher Chang, Kimberly Low, Yuli Song, Chengxu Liu, Walter Morales, Lemeesa Ali, Sheila Lezcano, Jeffery Conklin, Sydney Finegold.   

Abstract

RATIONALE: Two proposed hypotheses for irritable bowel syndrome (IBS) are acute gastroenteritis and bacterial overgrowth. We studied whether acute infection with Campylobacter could precipitate bacterial overgrowth in a rat model in order to link the two hypotheses.
METHODS: Sprague-Dawley outbred rats were randomly administered a vehicle or Campylobacter jejuni strain 81-176 by oral gavage. Three months after clearance of the infectious agent, rats had a stool consistency evaluation. After euthanasia, lumenal bacteria counts were measured via quantitative real-time PCR from self-contained segments of the duodenum, jejunum, ileum, cecum and left colon. Adjacent sections of bowel were fixed in formalin for evaluation of intraepithelial lymphocyte counts.
RESULTS: Three months after clearance of Campylobacter infection, 57% of Campylobacter infected rats had some alteration in stool consistency compared to 7.4% in mock-infected controls (P < 0.001). Among the rats that received Campylobacter, 27% had evidence of bacterial overgrowth by PCR. These rats also had the highest prevalence of altered stool form and had lower body weight. Consistent with post-infectious IBS in humans, bacterial overgrowth rats demonstrated a significant increase in rectal and left colon intraepithelial lymphocytes.
CONCLUSIONS: Acute infection with C. jejuni 81-176 precipitates alterations in stool consistency, bacterial overgrowth and rectal lymphocytosis consistent with findings in IBS patients.

Entities:  

Mesh:

Year:  2007        PMID: 17934822     DOI: 10.1007/s10620-007-9977-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set.

Authors:  Mangala A Nadkarni; F Elizabeth Martin; Nicholas A Jacques; Neil Hunter
Journal:  Microbiology       Date:  2002-01       Impact factor: 2.777

2.  The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial.

Authors:  Mark Pimentel; Sandy Park; James Mirocha; Sunanda V Kane; Yuthana Kong
Journal:  Ann Intern Med       Date:  2006-10-17       Impact factor: 25.391

3.  Small intestine bacterial overgrowth.

Authors:  C E King; P P Toskes
Journal:  Gastroenterology       Date:  1979-05       Impact factor: 22.682

4.  A migrating electric complex of canine small intestine.

Authors:  J H Szurszewski
Journal:  Am J Physiol       Date:  1969-12

5.  The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.

Authors:  G Vantrappen; J Janssens; J Hellemans; Y Ghoos
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

6.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

7.  Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients.

Authors:  K R Neal; J Hebden; R Spiller
Journal:  BMJ       Date:  1997-03-15

8.  Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study.

Authors:  Sally D Parry; Rosamund Stansfield; Diana Jelley; Wendy Gregory; Elizabeth Phillips; J Roger Barton; Mark R Welfare
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

9.  Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

Authors:  K R Neal; L Barker; R C Spiller
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

Authors:  Simon P Dunlop; David Jenkins; Keith R Neal; Robin C Spiller
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

View more
  30 in total

1.  Immune activation and gut microbes in irritable bowel syndrome.

Authors:  Khaldun Al-Khatib; Henry C Lin
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

Review 2.  Infectious diarrhea: an overview.

Authors:  Brandon Dickinson; Christina M Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2014-08

3.  ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.

Authors:  Sam-Ryong Jee; Walter Morales; Kimberly Low; Christopher Chang; Amy Zhu; Venkata Pokkunuri; Soumya Chatterjee; Edy Soffer; Jeffrey L Conklin; Mark Pimentel
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 4.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

5.  Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.

Authors:  Walter Morales; Ali Rezaie; Gillian Barlow; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2019-05-31       Impact factor: 3.199

Review 6.  The Traveling Microbiome.

Authors:  Mark S Riddle; Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

7.  Diagnostics: Filling in the missing pieces.

Authors:  Alla Katsnelson
Journal:  Nature       Date:  2016-05-19       Impact factor: 49.962

8.  The effect of rifaximin on gut flora and Staphylococcus resistance.

Authors:  Mi-Sung Kim; Walter Morales; Andres Ardila Hani; Sharon Kim; Gene Kim; Stacy Weitsman; Christopher Chang; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

9.  Chronic diarrhea in travelers.

Authors:  Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

Review 10.  Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.

Authors:  Jennifer K Beatty; Amol Bhargava; Andre G Buret
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.